lumateperone
Selected indexed studies
- Lumateperone. (, 2012) [PMID:34648250]
- Lumateperone for the Treatment of Schizophrenia. (Psychopharmacol Bull, 2020) [PMID:33012872]
- Lumateperone. (, 2006) [PMID:35877948]
_Worker-drafted node — pending editorial review._
Connections
lumateperone is a side effect of
Sources
- Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial. (2021) pubmed
- Lumateperone. (2012) pubmed
- Lumateperone for the Treatment of Schizophrenia. (2020) pubmed
- Lumateperone. (2006) pubmed
- Lumateperone: First Approval. (2020) pubmed
- Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial. (2020) pubmed
- Lumateperone: A Novel Antipsychotic for Schizophrenia. (2021) pubmed
- Lumateperone (Caplyta) for schizophrenia. (2020) pubmed
- Lumateperone for the Treatment of Major Depressive Disorder With Mixed Features or Bipolar Depression With Mixed Features: A Randomized Placebo-Controlled Trial. (2025) pubmed
- An evaluation of lumateperone tosylate for the treatment of schizophrenia. (2020) pubmed